Perfil
En la actualidad, Thomas Schfer ocupa el cargo de Director Científico y Vicepresidente Ejecutivo de Chr. Hansen Holding A. También forma parte del consejo del Instituto de Bioinnovación. En el pasado fue Director de Desarrollo de Negocios de Novozymes A. Se doctoró en la Universidad Libre de Berlín.
Últimas noticias acerca de Thomas Schäfer
Cargos activos de Thomas Schäfer
| Empresas | Cargo | Inicio |
|---|---|---|
Bioinnovation Institute
Bioinnovation Institute Investment ManagersFinance BioInnovation Institute invests in companies located in Europe. The firm targets companies operating in technology sectors such as therapeutics, health tech, planetary health and quantum tech. It provides financing for early stage capital requirements with an investment size ranging from DKK 7.86 to 14 million. | Director/Miembro de la Junta | - |
BacThera AG
BacThera AG Pharmaceuticals: MajorHealth Technology Manufactures bio therapeutic products | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Thomas Schäfer.
| Empresas | Cargo | Fin |
|---|---|---|
| CHRISTIAN HANSEN | Director Técnico/Científico/I+D | 31/03/2022 |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Corporate Officer/Principal | - |
Formación de Thomas Schäfer.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chr. Hansen Holding A/S
Chr. Hansen Holding A/S Food: Specialty/CandyConsumer Non-Durables Manufactures food cultures, enzymes and nutrition products | Consumer Non-Durables |
Bioinnovation Institute
Bioinnovation Institute Investment ManagersFinance BioInnovation Institute invests in companies located in Europe. The firm targets companies operating in technology sectors such as therapeutics, health tech, planetary health and quantum tech. It provides financing for early stage capital requirements with an investment size ranging from DKK 7.86 to 14 million. | Finance |
BacThera AG
BacThera AG Pharmaceuticals: MajorHealth Technology Manufactures bio therapeutic products | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Schäfer
















